Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils

Rina Kurihara, Yumi Tohyama, Satoshi Matsusaka, Hiromu Naruse, Emi Kinoshita, Takayuki Tsujioka, Yoshinao Katsumata, Hirohei Yamamura

Journal of Biological Chemistry · 2006 · 95 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

The possible role of the peripheral cannabinoid receptor (CB2) in neutrophil migration was investigated by using human promyelocytic HL60 cells differentiated into neutrophil-like cells and human neutrophils isolated from whole blood. Cell surface expression of CB2 on HL60 cells, on neutrophil-like HL60 cells, and on human neutrophils was confirmed by flow cytometry. Upon stimulation with either of the CB2 ligands JWH015 and 2-arachidonoylglycerol (2-AG), neutrophil-like HL60 cells rapidly extended and retracted one or more pseudopods containing F-actin in different directions instead of developing front/rear polarity typically exhibited by migrating leukocytes. Activity of the Rho-GTPase RhoA decreased in response to CB2 stimulation, whereas Rac1, Rac2, and Cdc42 activity increased. Moreover, treatment of cells with RhoA-dependent protein kinase (p160-ROCK) inhibitor Y27632 yielded cytoskeletal organization similar to that of CB2-stimulated cells. In human neutrophils, neither JWH015 nor 2-AG induced motility or morphologic alterations. However, pretreatment of neutrophils with these ligands disrupted N-formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLP)-induced front/rear polarization and migration and also substantially suppressed fMLP-induced RhoA activity. These results suggest that CB2 might play a role in regulating excessive inflammatory response by controlling RhoA activation, thereby suppressing neutrophil migration. The possible role of the peripheral cannabinoid receptor (CB2) in neutrophil migration was investigated by using human promyelocytic HL60 cells differentiated into neutrophil-like cells and human neutrophils isolated from whole blood. Cell surface expression of CB2 on HL60 cells, on neutrophil-like HL60 cells, and on human neutrophils was confirmed by flow cytometry. Upon stimulation with either of the CB2 ligands JWH015 and 2-arachidonoylglycerol (2-AG), neutrophil-like HL60 cells rapidly extended and retracted one or more pseudopods containing F-actin in different directions instead of developing front/rear polarity typically exhibited by migrating leukocytes. Activity of the Rho-GTPase RhoA decreased in response to CB2 stimulation, whereas Rac1, Rac2, and Cdc42 activity increased. Moreover, treatment of cells with RhoA-dependent protein kinase (p160-ROCK) inhibitor Y27632 yielded cytoskeletal organization similar to that of CB2-stimulated cells. In human neutrophils, neither JWH015 nor 2-AG induced motility or morphologic alterations. However, pretreatment of neutrophils with these ligands disrupted N-formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLP)-induced front/rear polarization and migration and also substantially suppressed fMLP-induced RhoA activity. These results suggest that CB2 might play a role in regulating excessive inflammatory response by controlling RhoA activation, thereby suppressing neutrophil migration. The peripheral cannabinoid receptor (CB2) 2The abbreviations used are: CB2, the peripheral cannabinoid receptor; CB1, the central cannabinoid receptor; PI3K, phosphatidylinositol 3-kinase; fMLP, N-formyl-l-methionyl-l-leucyl-l-phenylalanine; 2-AG, 2-arachidonoylglycerol; ATRA, all-trans-retinoic acid; MLC, myosin light chain; GFP-PKB/Akt-PH domain, the pleckstrin homology domain of PKB/Akt tagged with green fluorescent protein; PMN, polymorphonuclear granulocyte; PI3P, phosphatidylinositol 3,4,5-triphosphate and other products of PI3K; p160-ROCK, Rho-dependent protein kinase; HRP, horseradish peroxidase; BSA, bovine serum albumin; PBS, phosphate-buffered saline; GST, glutathione S-transferase. 2The abbreviations used are: CB2, the peripheral cannabinoid receptor; CB1, the central cannabinoid receptor; PI3K, phosphatidylinositol 3-kinase; fMLP, N-formyl-l-methionyl-l-leucyl-l-phenylalanine; 2-AG, 2-arachidonoylglycerol; ATRA, all-trans-retinoic acid; MLC, myosin light chain; GFP-PKB/Akt-PH domain, the pleckstrin homology domain of PKB/Akt tagged with green fluorescent protein; PMN, polymorphonuclear granulocyte; PI3P, phosphatidylinositol 3,4,5-triphosphate and other products of PI3K; p160-ROCK, Rho-dependent protein kinase; HRP, horseradish peroxidase; BSA, bovine serum albumin; PBS, phosphate-buffered saline; GST, glutathione S-transferase. was cloned in 1993 (1Munro S. Thomas K.L. Abu-Shaar M. Nature. 1993; 365: 61-65Crossref PubMed Scopus (4048) Google Scholar) after cloning of the central cannabinoid receptor (CB1) in 1990 (2Matsuda L.A. Lolait S.J. Brownstein M.J. Young A.C. Bonner T.I. Nature. 1990; 346: 561-564Crossref PubMed Scopus (4137) Google Scholar). It has been suggested that the gene encoding CB2 is a protooncogene and that aberrant expression of CB2 in myeloid precursor cells results in the development of leukemia by blocking neutrophil differentiation (3Valk P.J.M. Hol S. Vankan Y. Ihle J.N. Askew D. Jenkins N.A. Gilbert D.J. Copeland N.G. De Both N.J. Löwenberg B. Delwel R. J. Virol. 1997; 71: 6796-6804Crossref PubMed Google Scholar, 4Jordà M.A. Rayman N. Tas M. Verbakel S.E. Battista N. Van Lom K. Löwen-berg B. Maccarrone M. Delwel R. Blood. 2004; 104: 526-534Crossref PubMed Scopus (58) Google Scholar). CB2 is expressed predominantly in immune cells (5Galiègue S. Mary S. Marchand J. Dussossoy D. Carrière D. Carayon P. Bouaboula M. Shire D. Le Fur G. Casellas P. Eur. J. Biochem. 1995; 232: 54-61Crossref PubMed Scopus (1327) Google Scholar), and because of the diversity of immune cells, it is assumed that CB2 is involved in various activities in addition to inhibition of neutrophil differentiation (6Berdyshev E.V. Chem. Phys. Lipids. 2000; 108: 169-190Crossref PubMed Scopus (228) Google Scholar, 7Klein T.W. Newton C. Larsen K. Lu L. Perkins I. Nong L. Friedman H. J. Leukocyte Biol. 2003; 74: 486-496Crossref PubMed Scopus (421) Google Scholar, 8Sugiura T. Oka S. Gokoh M. Kishimoto S. Waku K. J. Pharmacol. Sci. 2004; 96: 367-375Crossref PubMed Scopus (45) Google Scholar, 9Croxford J.L. Yamamura T. J. Neuroimmunol. 2005; 167: 3-18Abstract Full Text Full Text PDF Scopus (206) Google Scholar). Steffens et al. (10Steffens S. Veillard N.R. Arnaud C. Pelli G. Burger F. Staub C. Zimmer A. Frossard J.-L. Mach F. Nature. 2005; 434: 782-786Crossref PubMed Scopus (360) Google Scholar) recently reported that doses of Δ9-tetrahydrocannabinol (the most psychoactive component of marijuana) too low to have psychotropic effects inhibit the progression of atherosclerosis via immunomodulatory effects on lymphoid and myeloid cells. This report indicates that CB2 may be involved in a wide range of physiologic phenomena related to immunity and that some CB2 ligands may have application in the treatment of inflammatory disease. However, research into CB2 is still in its early stages. In particular, the involvement of only a few molecules, Gαi/Gαo protein, phosphatidylinositol 3-kinase (PI3K), and members of the mitogen-activated protein kinase and nuclear factor-κB families, in the CB2 signaling pathways has been reported (6Berdyshev E.V. Chem. Phys. Lipids. 2000; 108: 169-190Crossref PubMed Scopus (228) Google Scholar, 7Klein T.W. Newton C. Larsen K. Lu L. Perkins I. Nong L. Friedman H. J. Leukocyte Biol. 2003; 74: 486-496Crossref PubMed Scopus (421) Google Scholar, 8Sugiura T. Oka S. Gokoh M. Kishimoto S. Waku K. J. Pharmacol. Sci. 2004; 96: 367-375Crossref PubMed Scopus (45) Google Scholar, 11Kaminski N.E. J. Neuroimmunol. 1998; 83: 124-132Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar). Among the possible roles of CB2 in immunity is the induction of leukocyte migration to sites of infection and inflammation, an important step in the host defense against pathogenic microorganisms. CB2 is a seven-transmembrane, Gαi/Gαo protein-coupled receptor, as are receptors for chemoattractants such as N-formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLP). It has been reported that several genes encoding chemotactic cytokines are up-regulated in response to CB2 stimulation (12Derocq J.-M. Jbilo O. Bouaboula M. Ségui M. Clère C. Casellas P. J. Biol. Chem. 2000; 275: 15621-15628Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar). Indeed, 2-arachidonoylglycerol (2-AG), a physiological ligand for both CB1 and CB2 (13Sugiura T. Kondo S. Sukagawa A. Nakane S. Shinoda A. Itoh K. Yamashita A. Waku K. Biochem. Biophys. Res. Commun. 1995; 215: 89-97Crossref PubMed Scopus (1783) Google Scholar, 14Mechoulam R. Ben-Shabat S. Hanus L. Ligumsky M. Kaminski N.E. Schatz A.R. Gopher A. Almog S. Martin B.R. Compton D.R. Pertwee R.G. Griffin G. Bayewitch M. Barg J. Vogel Z. Biochem. Pharmacol. 1995; 50: 83-90Crossref PubMed Scopus (2302) Google Scholar), can induce migration in some subpopulations of hematopoietic cells (8Sugiura T. Oka S. Gokoh M. Kishimoto S. Waku K. J. Pharmacol. Sci. 2004; 96: 367-375Crossref PubMed Scopus (45) Google Scholar, 15Jordà M.A. Verbakel S.E. Valk P.J.M. Vankan-Berkhoudt Y.V. Maccarrone M. Finazzi-Agrò A. Löwenberg B. Delwel R. Blood. 2002; 99: 2786-2793Crossref PubMed Scopus (140) Google Scholar, 16Walter L. Franklin A. Witting A. Wade C. Xie Y. Kunos G. Mackie K. Stella N. J. Neurosci. 2003; 23: 1398-1405Crossref PubMed Google Scholar). However, contradictory findings have been reported by other researchers (10Steffens S. Veillard N.R. Arnaud C. Pelli G. Burger F. Staub C. Zimmer A. Frossard J.-L. Mach F. Nature. 2005; 434: 782-786Crossref PubMed Scopus (360) Google Scholar, 17Sacerdote P. Massi P. Panerai A.E. Parolaro D. J. Neuroimmunol. 2000; 109: 155-163Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar, 18Deusch E. Kraft B. Nahlik G. Weigl L. Hohenegger M. Kress H.G. J. Neuroimmunol. 2003; 141: 99-103Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar, 19Joseph J. Niggemann B. Zaenker K.S. Entschladen F. Cancer Immunol. Immunother. 2004; 53: 723-728Crossref PubMed Scopus (137) Google Scholar), in part due to differences in ligands and cells used. In particular, Steffens et al. (10Steffens S. Veillard N.R. Arnaud C. Pelli G. Burger F. Staub C. Zimmer A. Frossard J.-L. Mach F. Nature. 2005; 434: 782-786Crossref PubMed Scopus (360) Google Scholar) reported that Δ9-tetrahydrocannabinol inhibits monocyte chemoattractant protein 1-induced macrophage migration, a crucial step in the progression of atherosclerosis. In the present study, the possible role of CB2 in neutrophil migration was investigated. We constructed an in vitro model of neutrophil migration on blood vessels as described previously (20Miura Y. Tohyama Y. Hishita T. Lala A. De E. Y. H. T. Tohyama K. Blood. 2000; 96: PubMed Google Scholar) with some human promyelocytic HL60 cells, differentiated by all-trans-retinoic into neutrophil-like cells, on with an We that CB2 2-AG and a ligand induce motility of the cells that the cells the front/rear polarity that migrating typically with a the and a the F. M.A. J. PubMed Scopus Google Scholar, Cell Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). In to the possible physiological of the the effects of the CB2 and as pretreatment stimulation, in human neutrophils isolated from whole blood. We that pretreatment of human neutrophils with the ligands fMLP-induced front/rear polarization and migration. and was from The and the and from The was from The and from The the the myosin light and the from Cell The and from The and from was from was from JWH015 and 2-AG from CB2 inhibitor was by CB1 inhibitor was from was from Y27632 was from Cell promyelocytic HL60 cells in with serum in an of and HL60 cells and HL60 cells the pleckstrin homology domain of PKB/Akt tagged with green fluorescent protein induced to into neutrophil-like cells by treatment with for polymorphonuclear isolated from whole blood by with the the with for and with expression on the surface was by flow for with in phosphate-buffered containing bovine serum and with The cells for with and with to flow with a of these and domain of human protein kinase was from human with the and The was with that and sites and the products cloned into the the of both with the into cells. Cell by and to for the of with GFP-PKB/Akt-PH domain was into HL60 cells by Cell of cells was as described previously S. Tohyama Y. J. Y. R. T. R. Tohyama K. Yamamura H. Biochem. Biophys. Res. Commun. 2005; PubMed Scopus Google Scholar) with some In cells in a or was on the of a to an to for in and with either of ligands or a of ligands from a Cell and motility by for cells present cells in the the Cell and with In particular, by of morphologic by cells of for cells in with for with containing and and with in for to receptors was by for with containing and CB2 with for This was with the of a to the with with the fluorescent cytoskeletal cells with for with cells with and for of the of cells with The to for of of these cells with in and by with an and an with Rho-GTPase of Rac1, Rac2, and isolated by protein to the of and was as described previously T. Yamamura H. K. 2004; PubMed Scopus Google Scholar). In of the and domain of human was cloned into expression as a protein with glutathione and was expressed in cells with The protein was with of protein to the of and of the domain of was cloned to the of et al. M.A. J. PubMed Scopus Google Scholar). to for HL60 cells and human neutrophils with 2-AG, or to Rho-GTPase activity M.A. J. PubMed Scopus Google Scholar) and because cells are to in Biol. 2002; PubMed Scopus Google Scholar), cells in in a The cells for in containing and Cell for of was in for for of and The with either or for by with to the by in for with for to activity of the used in PKB/Akt and cells in a containing and by and to The with in for with to Rac1, Rac2, or for and with a containing and The with Rac1, or or RhoA and for and with and with with and a the of was with and PKB/Akt and immune of with PKB/Akt and that with by the in a containing and for and the with either or was by with a of CB2 on the of HL60 and cells are to and into neutrophil-like cells with S.E. S.J. Sci. PubMed Scopus Google Scholar). We CB2 expression in HL60 cells, in HL60 cells after to HL60 and in human isolated from whole blood. flow CB2 was on the surface of these cells The surface expression of CB2, as by in HL60 HL60 cells and similar to other to flow confirmed by that of HL60 cells and of the neutrophils Moreover, CB2 expression in these cells was confirmed by We also nuclear with and confirmed that HL60 cells induced to into neutrophil-like cells and that most of the neutrophils similar of CB2 expression in neutrophil-like HL60 cells and in human neutrophils used neutrophil-like HL60 cells as an in vitro model of human neutrophils in JWH015 and 2-AG with in HL60 in motility and of neutrophil-like HL60 cells stimulation with either JWH015 or 2-AG physiological ligand for both CB1 and by cells with after JWH015 or 2-AG stimulation, of the cells rapidly and one or more pseudopods in different directions for These cells the front/rear polarity that migrating typically and activity of to of JWH015 by also induced polarization by the of one or more pseudopods in different directions of of or with of the CB2 ligands is in in cells from cells, cells with a of as is the the and is the to as in the to The of cells after stimulation with the CB2 ligands This was by pretreatment with CB2 inhibitor by CB1 inhibitor In the of cells that extended pseudopods after CB2 stimulation of the cells that in response to the CB2 ligands of a of the the of migrating In of the cells to of exhibited front/rear with a the and a the and an of a is in the to F-actin in the in CB2-stimulated cytoskeletal the morphologic CB2 stimulation was investigated by of F-actin and In a only F-actin was the and from a an of extended to the of cells are In one with a a of F-actin was in the from a In the other F-actin was in or and from a to GFP-PKB/Akt-PH in or in HL60 cells GFP-PKB/Akt-PH domain, a for phosphatidylinositol 3,4,5-triphosphate and other products of P. T. J. Cell Biol. 1998; PubMed Scopus Google Scholar, J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar), induced to into neutrophil-like cells by treatment with and with of GFP-PKB/Akt-PH domain was by In cells that exhibited morphologic in response to CB2 stimulation, GFP-PKB/Akt-PH domain in one or more in pseudopods and JWH015 RhoA Activity in HL60 in cytoskeletal and migration, Rac1, Rac2, and play important The effects of CB2 stimulation on the activities of these by of can be The of Rac1, Rac2, and Cdc42 activities are in RhoA activity decreased after JWH015 stimulation In activity rapidly and the activity also more and to a of Cdc42 activity more We also that activity of kinase PKB/Akt rapidly in response to JWH015 stimulation, a to the Rho-dependent (p160-ROCK) Y27632 to of the that decreased RhoA activity is with the CB2 morphologic the effects of Rho-dependent protein kinase (p160-ROCK) inhibitor Y27632 on The of cells in response to Y27632 of the cells that to Y27632 motility and morphologic similar to CB2-stimulated extended and retracted one or more pseudopods in different directions that most cells in with Y27632 exhibited cytoskeletal organization similar to that of cells JWH015 Activity in HL60 effects of CB2 stimulation on activity of a of p160-ROCK, In response to JWH015 stimulation, of to and after stimulation This was confirmed by In neutrophil-like HL60 cells, low of In response to JWH015 stimulation, the in JWH015 and 2-AG fMLP-induced and of neutrophils with either JWH015 or 2-AG and to migration motility or morphologic in response to either ligand and whereas and activity an in response to CB2 The CB2 in and activities was suppressed by CB2 inhibitor and These results suggest that CB2 receptors and that and to motility and morphologic in human of JWH015 and 2-AG on migration in human neutrophils isolated from whole blood and to migration and or Rho-GTPase and of the of with JWH015 2-AG or and with after pretreatment with either JWH015 or 2-AG for and effects of JWH015 or stimulation on and in In of these activity in neutrophils in neutrophils after stimulation with JWH015 or the stimulation after pretreatment with CB2 inhibitor for The are of the of and the of and the of was with and the of to and to the of of the of and and with JWH015 2-AG or for with after pretreatment with either JWH015 or 2-AG for with after pretreatment with JWH015 in the of CB2 inhibitor for with after pretreatment with 2-AG in the of either CB2 inhibitor or CB1 inhibitor for was from the of for or from to after 2-AG, or The the of one of RhoA activity in neutrophils in neutrophils with JWH015 2-AG or for and in neutrophils with for after pretreatment with either JWH015 or 2-AG for The are of The the of and the the of and The was as described for B. of cells in the of human neutrophils described for A. for The the of In to the of motility and morphologic in response to the CB2 more of neutrophils to front/rear and to after stimulation The effects of pretreatment with JWH015 or 2-AG on fMLP-induced front/rear polarization and migration investigated. cells also exhibited motility and morphologic in response to However, most front/rear extended one or more pseudopods in different directions and The was from the of from to after stimulation, was by JWH015 or 2-AG pretreatment for This of 2-AG, a ligand for both CB1 and CB2, on fMLP-induced neutrophil migration was substantially by CB2 inhibitor by CB1 inhibitor similar of was with JWH015 pretreatment In neutrophil-like HL60 cells, JWH015 stimulation decreased RhoA activity as described In the effects on RhoA activity of the CB2 and as pretreatment stimulation, in human stimulation with JWH015 for induced in RhoA stimulation with 2-AG for decreased RhoA activity. with for RhoA activity. with both JWH015 and 2-AG for substantially suppressed the in RhoA activity induced by In neither ligand the of cells in response to Upon stimulation with chemoattractants such as fMLP, rapidly from a to an with front/rear polarity and It was that these by of cells a CB2 stimulation be an in the role of CB2 in neutrophil migration. by for after to the CB2 We that both JWH015 and 2-AG induced motility and previously morphologic (the of one or more in neutrophil-like HL60 cells The CB2 by pretreatment with CB2 inhibitor by CB1 inhibitor that the In GFP-PKB/Akt-PH domain, is to the of migrating J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, G. P. T. 2000; PubMed Scopus Google Scholar), in one or more pseudopods in CB2-stimulated cells and This indicates that CB2 induce front/rear In cells to front/rear polarity and with previously reported findings in neutrophil-like HL60 cells J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, G. P. T. 2000; PubMed Scopus Google Scholar). These results that the cells the to front/rear polarity and that the morphologic a to CB2 stimulation, different from induced by other a step in the by the CB2 ligands induce the morphologic the effects of CB2 stimulation on Rac1, Rac2, and Cdc42 activities in neutrophil-like HL60 cells. Activity of these the different RhoA activity decreased activity rapidly a activity also more and to a and Cdc42 activity more still may that the in expressed of and of in activity that these effects and are also in neutrophils, as reported by the M. F. A. I. P. M. D.J. J. Immunol. 2003; PubMed Scopus Google Scholar, Z. G. C. Z. D. Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). was on the in RhoA activity because the results to RhoA activity stimulation in neutrophil-like HL60 cells J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). In that pretreatment of human neutrophils with JWH015 or 2-AG substantially suppressed fMLP-induced RhoA activity and also disrupted fMLP-induced front/rear These results to that decreased RhoA activity is involved in the morphologic induced by the CB2 We investigated the effects of Rho-dependent protein kinase (p160-ROCK) inhibitor We the morphologic induced by Y27632 and induced by JWH015 and et al. J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar) reported that of RhoA Y27632 and a RhoA fMLP-induced polarization and induce of pseudopods in neutrophil-like HL60 cells. results are with and that the morphologic induced by the CB2 ligands are in to of the have that myosin is a of p160-ROCK, in its M. M. K. Y. K. T. Y. K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, Y. Y. N. M. T. M. F. M. K. J. Cell Biol. PubMed Scopus Google Scholar). by myosin are to to polarization Biol. 2002; PubMed Scopus Google Scholar, P.J.M. Biol. 2004; PubMed Scopus Google Scholar). et al. J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar) reported that to a myosin neutrophil-like HL60 cells to on these that the CB2 ligands induced the morphologic by suppressing the However, to activity in neutrophil-like HL60 cells JWH015 stimulation and of is that CB2 stimulation might activity other pathways that It is reported that the kinase in N. M. K. A. J. Cell Sci. 2003; PubMed Scopus Google Scholar). This may have induced We that the effects of CB2 ligands on of activity. to the roles of RhoA and in cytoskeletal and the have been RhoA a role in the and in the Cell Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, P.J.M. Biol. 2004; PubMed Scopus Google a role in the and in the containing F-actin F. M.A. J. PubMed Scopus Google Scholar, Cell Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, Z. G. C. Z. D. Biol. 2005; Full Text Full Text PDF PubMed Scopus Google RhoA-dependent inhibit and J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). It is also in addition to the are of cytoskeletal and that of the is in F-actin in J. F. Van A. P. A. K. Y. N. T. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, G. P. T. 2000; PubMed Scopus Google Scholar, P.J.M. Biol. 2004; PubMed Scopus Google Scholar). et al. Z. Z. N. Y. L. T. R. L. D. Cell Biol. 2005; PubMed Scopus Google Scholar) that the of migrating neutrophils, p160-ROCK, in and In the present study, most neutrophil-like HL60 cells that to the CB2 ligands or more containing GFP-PKB/Akt-PH domain for and in the of a We also that CB2 stimulation decreased and PKB/Akt on results are with the previously reported In particular, results with of et al. Z. Z. N. Y. L. T. R. L. D. Cell Biol. 2005; PubMed Scopus Google Scholar), the a in RhoA activity to of a and a in activity. In the of p160-ROCK, is is of is suppressed in of the in F-actin in one or more is to the involvement of in CB2 morphologic alterations. have that RhoA activity is to in J. Cell Sci. 2003; PubMed Scopus Google Scholar, Y. J. N. M. Cell Biol. 2004; PubMed Scopus Google Scholar, J. F. Van A. M. Sci. S. A. 2005; PubMed Scopus Google Scholar, O. F. B. A. S. S. P. J. Cell Sci. 2005; PubMed Scopus Google Scholar). In particular, J. Cell Sci. 2003; PubMed Scopus Google Scholar) reported that activity. In the present that CB2 stimulation decreased RhoA effects of CB2 on are However, it is possible that CB2 via cytoskeletal In the present study, that in neutrophil-like HL60 cells JWH015 and 2-AG induce motility and morphologic by front/rear polarization and activity. The induced via of the In the of human neutrophils, pretreatment of cells with the CB2 ligands disrupted fMLP-induced front/rear polarization and and also substantially suppressed fMLP-induced RhoA activity Leukocyte polarization is to to migration to sites of infection and the of the CB2 ligands on neutrophil and that pretreatment with JWH015 or 2-AG migration induced by is a chemotactic by It is that is present in 2-AG is It has been that or and 2-AG T. Y. Oka S. Waku K. 2002; Full Text PDF PubMed Scopus Google Scholar). These cells can in the of by inflammatory cells such as these that CB2 a role in regulating excessive inflammatory response in by controlling RhoA activation, thereby suppressing neutrophil migration.

References

32